Replies to post #47470 on Cytodyn Inc (CYDY)

[finesand]

sure, possible and sensible as suitor would want to have that as well

when I played with the numbers, 50% on net sales (less rebates),
is A LOT to be honest.

reason why I added the 30% on sales case, knowing that ~22.6% means 50% of profits on average pharma costs/margins.

so as a heads up: If NP gets a deal done for >= 20% on net sales, it is already awesome - just that people understand the numbers.
From this number on, the pharma is willing to earn less than the IP owner CYDY.

How could a pharma offer such a high percentage of the whole cake, i.e. 50% on sales -> 70%+ on profits? It must be a really high margin, low production costs and sort of no advertising required.
IMHO a BP not a small one - at least a very experienced one knowing their numbers pretty well.

Just a little debate on the details ..

EDITED: Or .. they get a bigger cake for another country. Also possible (o8>

[Grip it and Sip It]

What deal? Do you have any specifics? Did I miss something? There is only Naders chatter about some “sort” if deal.

With his track record, he’ll say no or the other company will low-ball to make him desperate. It’s a proven negotiating tool to build up anticipation then recalibrate the expectations. The problem is Nader is really running out of options and suitors

Grip